Thalidomide and Breast cancer - a phase IV clinical study of FDA data

Summary:

Breast cancer is reported as a side effect among people who take Thalidomide (thalidomide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Velcade, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Breast cancer when taking Thalidomide. It is created by eHealthMe based on reports of 16,470 people who have side effects when taking Thalidomide from the FDA, and is updated regularly.

What is Thalidomide?

Thalidomide has active ingredients of thalidomide. eHealthMe is studying from 16,473 Thalidomide users. Check the latest studies of Thalidomide.

What is Breast cancer?

Breast cancer is found to be associated with 1,295 drugs and 1,665 conditions by eHealthMe. Check the latest studies of Breast cancer.

On Jul, 06, 2026

16,470 people reported to have side effects when taking Thalidomide.
Among them, 68 people (0.41%) have Breast cancer.

Among these 68 people:

How long have people been on Thalidomide when they have Breast cancer? *

What is the gender of people who have Breast cancer when taking Thalidomide? *

female: 98.11 %
male: 1.89 %

What is the age of people who have Breast cancer when taking Thalidomide? *

What are other drugs people take besides Thalidomide? *

Revlimid: 20 people, 29.41%
Velcade: 20 people, 29.41%
Dexamethasone: 16 people, 23.53%
Zometa: 13 people, 19.12%
Aredia: 12 people, 17.65%
Melphalan Hydrochloride: 12 people, 17.65%
Benadryl: 11 people, 16.18%
Decadron: 10 people, 14.71%
Darzalex: 9 people, 13.24%
Levaquin: 8 people, 11.76%

What are other side effects people have besides Breast cancer? *

Pain: 14 people, 20.59%
Acute Kidney Failure: 13 people, 19.12%
Deformity (disfigurement): 13 people, 19.12%
Neoplasm Malignant (cancer tumour): 13 people, 19.12%
Neuropathy Peripheral (surface nerve damage): 12 people, 17.65%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 12 people, 17.65%
Thrombocytopenia (decrease of platelets in blood): 12 people, 17.65%
Osteonecrosis Of Jaw (death of bone of jaw): 12 people, 17.65%
Gait Disturbance: 11 people, 16.18%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 11 people, 16.18%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 58 people, 85.29%
Neoplasm Malignant (cancer tumour): 6 people, 8.82%
Diabetes: 5 people, 7.35%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 5.88%
Birth Control: 3 people, 4.41%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 2.94%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 2.94%
Erythema Nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below): 1 person, 1.47%
Bone Loss: 1 person, 1.47%
Cachexia (loss of weight): 1 person, 1.47%

* Approximation only. Some reports may have incomplete information.

Do you take Thalidomide and have Breast cancer?

- Check whether Breast cancer is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Thalidomide:

Thalidomide (16,473 reports)

Breast cancer treatments and more:

Breast cancer (266,434 reports)

Browse all side effects of Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Breast cancer:

Breast cancer (1,296 drugs)

Browse all the conditions that are associated with Breast cancer:

Breast cancer (1,665 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on thalidomide (the active ingredients of Thalidomide) and Thalidomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.